6S Pharma LLC., a start-up founded in 2023, operates at the intersection of the Health Care and Pharmaceutical industries. With a keen focus on innovation, the company embodies its slogan, “Development by Design.”
Headquartered in the United States, 6S Pharma LLC. is advancing its portfolio with three products currently in the Pre-IND phase. Additionally, it has a robust pipeline featuring several complex generics, signaling a strong potential to disrupt the market with novel therapeutic options.
The company most recently received a Seed investment on 01 September 2023. While the details of the investors remain undisclosed, this funding round underscores a growing interest and confidence in 6S Pharma LLC.'s mission and strategy.
Overall, with its strategic approach and commitment to pharmaceutical innovation, 6S Pharma LLC. offers a compelling opportunity for investors with a keen interest in early stage developments within the pharmaceutical sector.